Monday, February 4, 2013
Stemline Therapeutics Inc., of New York, closed its initial public offering of 3.8 million shares, including the exercise in full of the overallotment option covering 497,647 shares, at a price of $10 per share.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.